Radiopharmaceuticals: all 1,299 studies that test it
Page 1 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.
- Flutemetamol F 18 Injection Formulation ComparisonNot yet recruitingNCT07873463Phase 2
- Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate CancerNot yet recruitingNCT07860554Phase 2
- A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate CancerRecruitingNCT07853209Phase 3
- This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.RecruitingNCT07830654Phase 2
- Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CARecruitingNCT07829705Phase 2
- Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07828249Phase 1
- Imaging Mitochondrial Complex-I in Alcohol Use DisorderRecruitingNCT07825818Early Phase 1
- Right Colon Enema to Improve Bowel Preparation Quality During ColonoscopyNot yet recruitingNCT07813013Not applicable
- Study to Evaluate the Efficacy and Safety of 177Lu-NYM032 Injection in Participants With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)Not yet recruitingNCT07795268Phase 3
- Evaluation of Iopofosine I 131 vs. R-CD in WM PatientsNot yet recruitingNCT07766421Phase 3
- Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.RecruitingNCT07752784Phase 3
- 68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal TherapyNot yet recruitingNCT07747493Not applicable
- [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)Not yet recruitingNCT07723651Phase 2
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialRecruitingNCT07698535Phase 2
- Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07682649Phase 1
- Phosphate in Acute PancreatitisRecruitingNCT07681050Phase 2
- Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy DeliveryNot yet recruitingNCT07674771Early Phase 1
- Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal MetastasesNot yet recruitingNCT07674693Phase 1
- CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaRecruitingNCT07659678Phase 2
- Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular CarcinomaNot yet recruitingNCT07657273Phase 2
- Optimal Application Timing of ADC Drugs for Advanced Breast CancerRecruitingNCT07657130Phase 2
- Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE TrialRecruitingNCT07650240Phase 2
- Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid TumorsRecruitingNCT07630961Phase 1
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine ImagingNot yet recruitingNCT07624760Not applicable
- Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT ImagingRecruitingNCT07613099Phase 3
- 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic CancerNot yet recruitingNCT07608627Phase 1
- Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate CancerRecruitingNCT07590934Phase 1/2
- A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic EfficacyRecruitingNCT07580703Phase 1
- Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisRecruitingNCT07572383Phase 2
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceRecruitingNCT07569926Phase 4
- A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPCRecruitingNCT07567521Phase 1/2
- Ultralow Dose PET Imaging of 18F-FDOPAEnrolling by invitationNCT07542158Phase 2
- FAP PET/CT for Staging Patients With Breast CancerNot yet recruitingNCT07523607Phase 2
- A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced CancerRecruitingNCT07505771Phase 1
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1RecruitingNCT07462507Phase 2
- Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown PrimaryNot yet recruitingNCT07434180Phase 2
- [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology IndicationsRecruitingNCT07432633Phase 1/2
- Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive FunctionRecruitingNCT07422857Phase 3
- A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)RecruitingNCT07416552Phase 1
- Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI FindingsNot yet recruitingNCT07360548Phase 2
- Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)RecruitingNCT07357519Phase 1/2
- Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromeRecruitingNCT07350707Phase 1/2
- A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease ManifestationsRecruitingNCT07325253Phase 2
- Phase 1 Study of CLR 125 in Triple Negative Breast CancerRecruitingNCT07311993Phase 1
- Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and ParagangliomaRecruitingNCT07288931Not applicable
- Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillanceRecruitingNCT07285057Phase 2
- Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakeRecruitingNCT07284589Phase 2
- Ultralow Dose PET Imaging of 18F-flurpiridazEnrolling by invitationNCT07284576Phase 2
- Ultralow Dose PET Imaging for 18F-NaF UptakeRecruitingNCT07284563Phase 2
- A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.Not yet recruitingNCT07272642Phase 1
- Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid TumorsRecruitingNCT07261631Phase 1
- A Study of 177Lu-PSMA-617 in People With GliomasRecruitingNCT07223034Phase 1
- POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsRecruitingNCT07220720Phase 2
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07217717Phase 3
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.RecruitingNCT07217704Phase 3
- A Study of LY4337713 in Participants With FAP-Positive Solid TumorsRecruitingNCT07213791Phase 1
- 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRIRecruitingNCT07209878Phase 2/3
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic CancerRecruitingNCT07197671Phase 1
- Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone PainRecruitingNCT07197645Phase 1
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRecruitingNCT07189871Phase 1/2
- An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.RecruitingNCT07185165Phase 2
- Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RecruitingNCT07165132Phase 1
- Repurposing Tilmanocept for Cardiac SarcoidosisRecruitingNCT07159074Phase 2
- Actinium Therapy for Late-stage Aggressive SarcomasRecruitingNCT07156565Phase 1
- RYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaRecruitingNCT07150806Phase 1/2
- Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate AdenocarcinomaRecruitingNCT07150715Phase 2
- Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.RecruitingNCT07150546Phase 1
- A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese AdultsRecruitingNCT07149831Phase 1
- 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerRecruitingNCT07145177Phase 1
- Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.RecruitingNCT07144085Phase 1
- An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine CancerRecruitingNCT07132645Early Phase 1
- Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate CancerRecruitingNCT07115277Not applicable
- FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruitingNCT07114939Phase 1
- Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaRecruitingNCT07100730Phase 3
- Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesRecruitingNCT07098806Phase 1/2
- Glucose Consumption in MS Using [F-18]FDG-PETRecruitingNCT07087106Phase 4
- A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart FailureRecruitingNCT07083011Phase 2
- CAIX PET/CT for Residual or Recurrent Post-ablative ccRCCNot yet recruitingNCT07077083Phase 2
- Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal CellRecruitingNCT07062549Phase 1
- Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CTRecruitingNCT07062523Phase 1/2
- A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETsRecruitingNCT07057622Phase 3
- Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617RecruitingNCT07054346Phase 1
- Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's DiseaseRecruitingNCT07020026Phase 2
- Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentRecruitingNCT07011342Not applicable
- Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)Not yet recruitingNCT07007325Early Phase 1
- Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid TumorsRecruitingNCT07006727Phase 1
- 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerNot yet recruitingNCT06991738Phase 1/2
- A Multimodal Imaging Study of Dopamine in Early PsychosisNot yet recruitingNCT06977308Phase 1
- Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadRecruitingNCT06974877Phase 1
- Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617RecruitingNCT06972628Phase 2
- Lu-177 PSMA Treatment in Cell Renal CarcinomaNot yet recruitingNCT06959433Phase 3
- Ultralow Dose PET Imaging of 18F-FDG UptakeRecruitingNCT06956391Phase 2
- Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)RecruitingNCT06943495Phase 1
- Imaging of Solid Tumors Using 18F-TRXRecruitingNCT06942104Phase 1
- PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)RecruitingNCT06920628Phase 1
- Ultralow Dose PET Imaging for PSMA ExpressionRecruitingNCT06904313Phase 2
- Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid CancerRecruitingNCT06898437Early Phase 1
- PET [89Zr]DFO-starPEG in Solid TumorsRecruitingNCT06894745Phase 1
- PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)RecruitingNCT06871176Not applicable